The most supported model is that pathogenic G2019S shifts the basal catalytic set-point upward, producing higher baseline phospho-Rab output while leaving the core lysosomal volume-sensing response architecture largely intact. In this view, mutant cells begin from a higher activity floor, and the key experimental discriminator is whether baseline-normalized EC50, slope, or Emax materially increase during graded swelling.
Convergent vs Divergent Predictions
This summary checks where the selected hypotheses point toward the same target or mechanism, and where they pull in opposite directions.
LRRK2Lysosomalneurodegeneration
Convergent signals
LRRK2 recurs across 2 selected hypotheses with aligned directionality in lysosomal.
Divergent signals
No direct polarity conflicts detected among the selected hypotheses.
Verdict Summary
3/11
dimensions won
LRRK2 Kinase Inhibition Reduces α-Synucl
9/11
dimensions won
G2019S primarily raises baseline LRRK2 k
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.65
0.86
Evidence
0.75
0.32
Novelty
0.55
0.48
Feasibility
0.55
0.91
Impact
0.78
0.88
Druggability
0.80
0.93
Safety
0.48
0.67
Competition
0.70
0.72
Data
0.70
0.82
Reproducible
0.68
0.80
KG Connect
0.50
0.50
Score Breakdown
Dimension
LRRK2 Kinase Inhibition Reduce
G2019S primarily raises baseli
Mechanistic
0.650
0.860
Evidence
0.750
0.320
Novelty
0.550
0.480
Feasibility
0.550
0.910
Impact
0.780
0.880
Druggability
0.800
0.930
Safety
0.480
0.670
Competition
0.700
0.720
Data
0.700
0.820
Reproducible
0.680
0.800
KG Connect
0.500
0.500
Evidence
LRRK2 Kinase Inhibition Reduces α-Synuclein Spread via Lysos
# Feasibility Assessment: Neurodegeneration Therapeutic Hypotheses
## Analytical Framework
This assessment evaluates each hypothesis across five domains:
1. **Druggability** — tractability of the ta...
1. **Title:** `G2019S raises the LRRK2 kinase floor more than the swelling gain`
**Mechanism:** G2019S may primarily increase constitutive catalytic output, producing higher baseline pRab10/pRa...
Skeptic
**Skeptical Read**
The main weakness across all six is the same: most cited evidence shows that mutant `LRRK2` can elevate phospho-Rab output or alter lysosomal remodeling, but it does **not** cleanl...
Domain Expert
As of **April 24, 2026**, the hypotheses that most credibly survive are:
1. **#1 Higher baseline kinase activity more than higher swelling gain**
2. **#4 Amplification is context-dependent and strong...
Synthesizer
{
"ranked_hypotheses": [
{
"title": "G2019S primarily raises baseline LRRK2 kinase activity rather than amplifying lysosomal swelling gain",
"description": "The most supported model ...